Clinical_JJ and_CC Taxonomic_JJ Status_NN of_IN Pathogenic_NP Nonpigmented_NP or_CC Late-Pigmenting_NP Rapidly_NP Growing_VBG Mycobacteria_NP The_DT history_NN ,_, taxonomy_NN ,_, geographic_JJ distribution_NN ,_, clinical_JJ disease_NN ,_, and_CC therapy_NN of_IN the_DT pathogenic_JJ nonpigmented_JJ or_CC late-pigmenting_VBG rapidly_RB growing_JJ mycobacteria_NNS (_( RGM_NP )_) are_VBP reviewed_VBN ._SENT Community-acquired_JJ disease_NN and_CC health_NN care-associated_JJ disease_NN are_VBP highlighted_VBN for_IN each_DT species_NN ._SENT The_DT latter_JJ grouping_NN includes_VBZ health_NN care-associated_JJ outbreaks_NNS and_CC pseudo-outbreaks_NNS as_RB well_RB as_IN sporadic_JJ disease_NN cases_NNS ._SENT Treatment_NN recommendations_NNS for_IN each_DT species_NN and_CC type_NN of_IN disease_NN are_VBP also_RB described_VBN ._SENT Special_JJ emphasis_NN is_VBZ on_IN the_DT Mycobacterium_NP fortuitum_NN group_NN ,_, including_VBG M._NP fortuitum_NP ,_, M._NP peregrinum_NN ,_, and_CC the_DT unnamed_JJ third_JJ biovariant_JJ complex_NN with_IN its_PP$ recent_JJ taxonomic_JJ changes_NNS and_CC newly_RB recognized_VBN species_NNS (_( including_VBG M._NP septicum_NN ,_, M._NP mageritense_NN ,_, and_CC proposed_VBD species_NNS M._NP houstonense_NP and_CC M._NP bonickei_NP )_) ._SENT The_DT clinical_JJ and_CC taxonomic_JJ status_NN of_IN M._NP chelonae_NNS ,_, M._NP abscessus_NP ,_, and_CC M._NP mucogenicum_NN is_VBZ also_RB detailed_JJ ,_, along_RB with_IN that_DT of_IN the_DT closely_RB related_VBN new_JJ species_NNS ,_, M._NP immunogenum_NN ._SENT Additionally_RB ,_, newly_RB recognized_VBN species_NNS ,_, M._NP wolinskyi_NP and_CC M._NP goodii_NP ,_, as_RB well_RB as_IN M._NP smegmatis_NN sensu_NN stricto_NN ,_, are_VBP included_VBN in_IN a_DT discussion_NN of_IN the_DT M._NP smegmatis_NN group_NN ._SENT Laboratory_NN diagnosis_NN of_IN RGM_NP using_VBG phenotypic_JJ methods_NNS such_JJ as_IN biochemical_JJ testing_NN and_CC high-performance_JJ liquid_JJ chromatography_NN and_CC molecular_JJ methods_NNS of_IN diagnosis_NN are_VBP also_RB discussed_VBN ._SENT The_DT latter_NN includes_VBZ PCR-restriction_NN fragment_NN length_NN polymorphism_NN analysis_NN ,_, hybridization_NN ,_, ribotyping_NN ,_, and_CC sequence_NN analysis_NN ._SENT Susceptibility_NN testing_NN and_CC antibiotic_JJ susceptibility_NN patterns_NNS of_IN the_DT RGM_NP are_VBP also_RB annotated_VBN ,_, along_RB with_IN the_DT current_JJ recommendations_NNS from_IN the_DT National_NP Committee_NP for_IN Clinical_NP Laboratory_NP Standards_NP (_( NCCLS_NP )_) for_IN mycobacterial_JJ susceptibility_NN testing_NN ._SENT The_DT species_NN of_IN rapidly_RB growing_VBG mycobacteria_NNS (_( RGM_NP )_) capable_JJ of_IN producing_VBG disease_NN in_IN humans_NNS consist_VBP primarily_RB of_IN the_DT Mycobacterium_NP fortuitum_NN group_NN ,_, the_DT M._NP chelonae/abscessus_NN group_NN ,_, and_CC the_DT M._NP smegmatis_NN group_NN ._SENT Key_JJ features_NNS for_IN identification_NN of_IN these_DT groups_NNS are_VBP the_DT presence_NN of_IN typical_JJ long-chain_NN fatty_NN acids_NNS known_VBN as_IN mycolic_JJ acids_NNS ,_, growth_NN of_IN readily_RB visible_JJ colonies_NNS on_IN primary_JJ isolation_NN within_IN 7_CD days_NNS on_IN multiple_JJ types_NNS of_IN solid_JJ media_NNS ,_, arylsulfatase_NN activity_NN within_IN 3_CD days_NNS or_CC 2_CD weeks_NNS ,_, and_CC the_DT absence_NN or_CC slow_JJ appearance_NN of_IN any_DT pigmentation_NN ._SENT Historically_RB ,_, the_DT M._NP fortuitum_NN group_NN has_VBZ been_VBN composed_VBN of_IN two_CD known_VBN species_NNS and_CC a_DT taxon_NN which_WDT has_VBZ been_VBN reported_VBN to_TO include_VB more_JJR than_IN one_CD species_NNS ._SENT The_DT species_NNS include_VBP M._NP fortuitum_NN (_( formerly_RB M._NP fortuitum_NN biovar_NN fortuitum_NN )_) ,_, M._NP peregrinum_NP (_( formerly_RB M._NP fortuitum_NN biovar_NN peregrinum_NN )_) and_CC the_DT taxon_NN known_VBN as_IN the_DT unnamed_JJ third_JJ biovariant_NN complex_NN ._SENT Several_JJ additional_JJ taxa_NNS to_TO be_VB discussed_VBN later_RBR are_VBP candidates_NNS for_IN inclusion_NN in_IN this_DT group_NN ._SENT M._NP chelonae_NNS (_( formerly_RB M._NP chelonae_NNS subsp_NN ._SENT chelonae_NNS )_) and_CC M._NP abscessus_NN (_( formerly_RB M._NP chelonae_NNS subsp_NN ._SENT abscessus_NN )_) ,_, along_RB with_IN the_DT newly_RB recognized_VBN species_NNS M._NP immunogenum_NN ,_, are_VBP members_NNS of_IN a_DT group_NN known_VBN collectively_RB as_IN the_DT M._NP chelonae-abscessus_NN group_NN ._SENT Finally_RB ,_, the_DT M._NP smegmatis_NN group_NN contains_VBZ M._NP smegmatis_NN sensu_NN stricto_NN and_CC two_CD newly_RB described_VBN species_NNS :_: M._NP goodii_NP ,_, and_CC M._NP wolinskyi_NP ._SENT Prior_RB to_TO recent_JJ molecular_JJ reevaluations_NNS ,_, the_DT taxa_NNS in_IN the_DT M._NP chelonae-abscessus_NN and_CC the_DT M._NP fortuitum_NN group_NN were_VBD considered_VBN "_`` subspecies_NN "_'' or_CC "_`` biovariants_NNS ,_, "_'' respectively_RB ._SENT However_RB ,_, the_DT introduction_NN and_CC evolution_NN of_IN 16S_JJ ribosomal_JJ gene_NN (_( rDNA_NN )_) sequencing_NP provided_VBD strong_JJ evidence_NN that_IN these_DT biovars_NNS and_CC subspecies_NN were_VBD in_IN fact_NN separate_JJ species_NNS ._SENT Gene_NP sequencing_NP also_RB permitted_VBD much_RB easier_JJR recognition_NN of_IN new_JJ taxa_NNS ,_, since_IN investigators_NNS could_MD use_VB data_NN banks_NNS for_IN strain_NN comparisons_NNS rather_RB than_IN performing_VBG the_DT much_RB more_RBR technically_RB difficult_JJ genomic_JJ DNA-DNA_NP pairing_VBG experiments_NNS with_IN all_DT potentially_RB related_VBN taxa_NNS ._SENT The_DT genomic_JJ DNA-DNA_NP pairing_VBG experiments_NNS that_WDT show_VBP <70_JJ %_NN homology_NN to_TO other_JJ species_NNS still_RB remain_VBP the_DT "_`` gold_JJ standard_NN "_'' for_IN recognition_NN of_IN new_JJ species_NNS ,_, but_CC such_JJ studies_NNS are_VBP performed_VBN infrequently_RB and_CC many_JJ new_JJ species_NNS of_IN mycobacteria_NNS are_VBP based_VBN genetically_RB on_IN 16S_JJ rDNA_NN comparisons_NNS only_RB ._SENT In_IN this_DT review_NN ,_, we_PP update_VBP the_DT taxonomy_NN of_IN these_DT nonpigmented_JJ RGM_NN and_CC point_NN out_IN many_JJ of_IN the_DT changes_NNS brought_VBD about_RB by_IN such_JJ newer_JJR technologies_NNS as_IN 16S_JJ rRNA_NN gene_NN sequencing_VBG ;_: high-performance_JJ liquid_JJ chromatography_NN (_( HPLC_NP )_) of_IN mycolic_JJ acid_JJ esters_NNS ,_, including_VBG fluorescence-HPLC_NN ;_: and_CC PCR_NP restriction_NN fragment_NN length_NN polymorphism_NN (_( RFLP_NP )_) analysis_NN (_( PRA_NP )_) of_IN a_DT 439-bp_JJ fragment_NN (_( referred_VBN to_TO as_IN the_DT Telenti_NP fragment_NN )_) of_IN the_DT 65-kDa_JJ heat_NN shock_NN protein-encoding_NN gene_NN (_( hsp65_NN )_) ._SENT Clinical_JJ disease_NN caused_VBN by_IN these_DT groups_NNS ,_, together_RB with_IN their_PP$ drug_NN susceptibility_NN ,_, and_CC most_RBS effective_JJ drug_NN treatment_NN are_VBP also_RB addressed_VBN ._SENT The_DT disease_NN syndromes_NNS caused_VBN by_IN these_DT organisms_NNS are_VBP listed_VBN in_IN Table_NP ._SENT The_DT nonpigmented_JJ RGM_NN are_VBP extremely_RB hardy_JJ and_CC thrive_VB in_IN even_RB the_DT most_RBS hostile_JJ of_IN environments_NNS (_( ,_, ,_, -_: )_) ._SENT Some_DT of_IN the_DT taxa_NNS --_: -such_NN as_IN a_DT subgroup_NN of_IN M._NP peregrinum_NP ,_, some_DT members_NNS of_IN the_DT unnamed_JJ third_JJ biovariant_JJ complex_NN of_IN M._NP fortuitum_NN ,_, and_CC most_JJS isolates_NNS in_IN the_DT M._NP smegmatis_NN group_NN --_: -are_NN able_JJ to_TO grow_VB at_IN 45C_JJ ._SENT Additionally_RB ,_, some_DT species_NN ,_, such_JJ as_IN the_DT M._NP chelonae/abscessus_NN group_NN and_CC M._NP mucogenicum_NN ,_, resist_VB the_DT activity_NN of_IN disinfectants_NNS and_CC biocides_NNS such_JJ as_IN organomercurials_NNS ,_, chlorine_NN ,_, and_CC alkaline_JJ glutaraldehyde_NN ._SENT These_DT hardy_JJ species_NN of_IN RGM_NP are_VBP commonly_RB seen_VBN in_IN municipal_JJ tap_NN water_NN ._SENT One_CD study_NN by_IN Carson_NP et_FW al._FW showed_VBD that_IN 55_CD %_NN of_IN the_DT incoming_JJ city_NN water_NN in_IN hemodialysis_NN centers_NNS throughout_IN the_DT United_NP States_NPS contained_VBD RGM_NP ._SENT Some_DT outbreaks_NNS of_IN human_JJ infection_NN related_VBN to_TO these_DT organisms_NNS have_VBP involved_VBN hospital_NN water_NN systems_NNS as_IN the_DT microbial_JJ reservoirs_NNS ._SENT Recently_RB ,_, the_DT presence_NN of_IN acid-fast_JJ mycobacteria_NNS in_IN up_IN to_TO 90_CD %_NN of_IN biofilms_NNS (_( the_DT slime_NN layer_NN present_JJ at_IN water-solid_JJ interfaces_NNS )_) taken_VBN from_IN piped_VBN water_NN systems_NNS has_VBZ been_VBN described_VBN ._SENT The_DT presence_NN of_IN acid-fast_JJ mycobacteria_NNS in_IN these_DT biofilms_NNS probably_RB serves_VBZ as_IN a_DT major_JJ environmental_JJ reservoir_NN for_IN organisms_NNS such_JJ as_IN M._NP kansasii_NP ,_, M._NP mucogenicum_NN ,_, M._NP simiae_NNS ,_, M._NP xenopi_NP ,_, and_CC M._NP gordonae_NNS ._SENT Because_IN of_IN the_DT ubiquity_NN of_IN the_DT RGM_NP ,_, human_JJ infections_NNS have_VBP been_VBN reported_VBN from_IN most_RBS geographic_JJ areas_NNS in_IN the_DT world_NN and_CC species_NN of_IN RGM_NP have_VBP been_VBN recovered_VBN from_IN 30_CD to_TO 78_CD %_NN of_IN soil_NN samples_NNS throughout_IN the_DT United_NP States_NPS ._SENT Most_RBS nosocomial_JJ (_( hereafter_RB referred_VBN to_TO as_IN health_NN care-associated_JJ )_) outbreaks_NNS and_CC pseudo-outbreaks_NNS have_VBP occurred_VBN in_IN the_DT United_NP States_NPS and_CC seem_VBP to_TO be_VB concentrated_VBN mainly_RB in_IN the_DT South_NP ._SENT M._NP senegalense_NN ,_, originally_RB found_VBN in_IN Africa_NP ,_, has_VBZ never_RB been_VBN described_VBN elsewhere_RB ._SENT Such_PDT a_DT localized_JJ distribution_NN among_IN the_DT RGM_NP seems_VBZ to_TO be_VB rare_JJ ,_, however_RB ._SENT Health_NP care-associated_JJ outbreaks_NNS and_CC pseudo-outbreaks_NNS commonly_RB involve_VBP exposure_NN to_TO tap_VB water_NN or_CC water_NN sources_NNS such_JJ as_IN ice_NN ,_, ice_NN water_NN ,_, and_CC water-based_JJ solutions_NNS ._SENT Contaminated_JJ ice_NN machines_NNS are_VBP a_DT relatively_RB important_JJ hospital_NN reservoir_NN for_IN the_DT RGM_NP ,_, especially_RB M._NP fortuitum_NN ._SENT Reported_VBN disease_NN outbreaks_NNS have_VBP included_VBN sternal_JJ wound_NN infections_NNS ,_, surgical_JJ wound_NN infections_NNS following_VBG plastic_JJ surgery_NN ,_, and_CC postinjection_NN abscesses_NNS ._SENT Catheter_NN infections_NNS also_RB have_VBP been_VBN associated_VBN with_IN the_DT RGM_NP ,_, including_VBG M._NP mucogenicum_NN ._SENT Pseudo-outbreaks_NNS of_IN disease_NN ,_, defined_VBN as_IN clusters_NNS of_IN false_JJ infections_NNS or_CC artifactual_JJ clustering_VBG of_IN real_JJ infections_NNS ,_, have_VBP been_VBN associated_VBN with_IN contaminated_JJ bronchoscopes_NNS and_CC automated_JJ endoscopic_JJ cleaning_NN machines_NNS with_IN tap_NN water_NN as_IN the_DT source_NN of_IN the_DT organism_NN ._SENT Localized_JJ infection_NN in_IN sporadic_JJ community-acquired_JJ disease_NN usually_RB occurs_VBZ after_IN a_DT traumatic_JJ injury_NN followed_VBN by_IN potential_JJ soil_NN or_CC water_NN contamination_NN ._SENT Such_JJ injuries_NNS as_IN stepping_VBG on_IN a_DT nail_NN ,_, motor_NN vehicle_NN accidents_NNS ,_, compound_JJ fractures_NNS ,_, etc._FW ,_, are_VBP typical_JJ of_IN the_DT clinical_JJ histories_NNS seen_VBN in_IN patients_NNS with_IN RGM_NP disease_NN ._SENT M._NP fortuitum_NP Group_NP |_SYM The_DT M._NP fortuitum_NN group_NN has_VBZ historically_RB included_VBN three_CD taxa_NNS :_: M._NP fortuitum_NP ,_, M._NP peregrinum_NN ,_, and_CC the_DT unnamed_JJ third_JJ biovariant_NN complex_NN ._SENT Here_RB ,_, we_PP propose_VBP the_DT addition_NN of_IN six_CD more_JJR species_NNS to_TO the_DT group_NN :_: M._NP mucogenicum_NN (_( for_IN reasons_NNS given_VBN below_IN )_) ,_, M._NP senegalense_NP ,_, M._NP mageritense_NN ,_, and_CC three_CD recently_RB described_VBD (_( M._NP F._NP Schinsky_NP ,_, M._NP P._NP Douglas_NP ,_, A._NP G._NP Steigerwalt_NP ,_, R._NP W._NP Wilson_NP ,_, M._NP M._NP Floyd_NP ,_, M._NP I._NP Daneshvar_NP ,_, B._NP A._NP Brown-Elliott_NP ,_, R._NP J._NP Wallace_NP ,_, Jr._NP ,_, M._NP M._NP McNeil_NP ,_, D._NP J._NP Brenner_NP ,_, and_CC J._NP M._NP Brown_NP ,_, Abstr_NP ._SENT 12th_JJ Int_NP ._SENT Symp_NP ._SENT Biol_NP ._SENT Actino_NN ._SENT ,_, abstr_NN ._SENT P-117_JJ ,_, 2001_CD )_) species_NN :_: M._NP septicum_NP ,_, M._NP houstonense_NN ,_, and_CC M._NP bonickei_NP ._SENT Few_JJ studies_NNS have_VBP accurately_RB separated_VBN these_DT eight_CD taxa_NNS ,_, and_CC they_PP were_VBD often_RB referred_VBN to_TO simply_RB as_IN "_`` M._NP fortuitum_NN ,_, "_'' as_RB if_IN they_PP were_VBD a_DT single_JJ species_NN ._SENT For_IN purposes_NNS of_IN this_DT review_NN ,_, "_'' M._NP fortuitum_NP group_NN "_`` is_VBZ used_VBN when_WRB no_DT subgrouping_NN was_VBD performed_VBN or_CC the_DT data_NNS include_VBP all_DT subgroups_NNS ._SENT Names_NNS of_IN the_DT specific_JJ taxa_NNS are_VBP used_VBN when_WRB the_DT isolates_NNS were_VBD so_RB identified_VBN by_IN current_JJ methods_NNS of_IN carbohydrate_NN utilization_NN or_CC PRA_NP of_IN the_DT hsp65_JJ gene_NN ._SENT Common_JJ features_NNS within_IN this_DT group_NN are_VBP a_DT positive_JJ 3-day_JJ arylsulfatase_NN ,_, the_DT absence_NN of_IN pigmentation_NN ,_, a_DT positive_JJ nitrate_NN reductase_NN ,_, a_DT positive_JJ iron_NN uptake_NN ,_, and_CC susceptibility_NN to_TO multiple_JJ drugs_NNS including_VBG polymyxin_NN B_NN ,_, sulfonamides_NNS ,_, and_CC the_DT newer_JJR fluoroquinolones_NNS ._SENT Most_JJS of_IN these_DT taxa_NNS grow_VBP better_JJR at_IN 30_CD than_IN 35C_JJ ._SENT Their_PP$ 16S_JJ rDNA_NN sequences_NNS generally_RB differ_VBP by_IN 15_CD bp_NN or_CC less_JJR ._SENT Historical_JJ perspective_NN ._SENT |_SYM (_( i_NP )_) M._NP fortuitum_NN ._SENT |_SYM M._NP fortuitum_NN was_VBD the_DT designation_NN given_VBN by_IN da_NP Costa_NP Cruz_NP to_TO a_DT strain_NN of_IN RGM_NP (_( ATCC_NP 6841T_NP )_) isolated_VBD from_IN a_DT human_JJ postinjection_NN abscess_NN in_IN 1938_CD ._SENT Subsequently_RB ,_, Stanford_NP and_CC Gunthorpe_NP determined_VBD that_IN the_DT isolate_NN was_VBD identical_JJ to_TO an_DT established_JJ species_NN known_VBN as_IN M._NP ranae_NNS ,_, with_IN the_DT type_NN strain_NN isolated_VBN from_IN a_DT frog_NN by_IN Kuster_NP in_IN 1905_CD ._SENT Runyon_NP challenged_VBD the_DT name_NN M._NP ranae_NNS ,_, in_IN part_NN because_IN many_JJ isolates_NNS identified_VBN as_IN M._NP ranae_NNS were_VBD subsequently_RB found_VBN to_TO be_VB M._NP smegmatis_NN and_CC in_IN part_NN because_IN the_DT name_NN M._NP fortuitum_NN was_VBD more_JJR widely_RB recognized_VBN and_CC established_VBN in_IN the_DT medical_JJ literature_NN ._SENT Hence_RB ,_, in_IN 1972_CD ,_, the_DT Judicial_NP Commission_NP of_IN the_DT International_NP Committee_NP of_IN Systematic_NP Bacteriology_NP of_IN the_DT International_NP Association_NP of_IN Microbiological_NP Societies_NP ruled_VBD in_IN favor_NN of_IN Runyon_NP 's_POS recommendation_NN to_TO maintain_VB the_DT species_NN designation_NN M._NP fortuitum_NN ,_, which_WDT has_VBZ remained_VBN to_TO the_DT present_NN ._SENT (_( ii_NP )_) M._NP peregrinum_NN ._SENT |_SYM M._NP peregrinum_NN was_VBD first_RB proposed_VBN in_IN 1962_CD when_WRB Bojalil_NP and_CC colleagues_NNS published_VBD the_DT first_JJ Adansonian_NP or_CC numerical_JJ classification_NN of_IN mycobacteria_NNS ._SENT This_DT analysis_NN separated_VBD mycobacteria_NNS into_IN 12_CD different_JJ categories_NNS or_CC branches_NNS based_VBN on_IN physiological_JJ characteristics_NNS ._SENT Branch_NN 1_CD consisted_VBN of_IN M._NP smegmatis_NP ,_, M._NP phlei_NP ,_, and_CC a_DT group_NN of_IN other_JJ strains_NNS that_WDT showed_VBD the_DT greatest_JJS metabolic_JJ capacity_NN of_IN all_PDT the_DT strains_NNS analyzed_VBD ._SENT The_DT name_NN M._NP peregrinum_NN sp_NN ._SENT nov_NP ._SENT was_VBD proposed_VBN for_IN this_DT latter_JJ group_NN (_( Latin_JJ adjective_NN meaning_VBG strange_JJ or_CC foreign_JJ )_) because_IN "_`` they_PP were_VBD the_DT only_JJ non-pigmented_JJ strains_NNS in_IN Branch_NP 1_CD "_'' ._SENT The_DT type_NN strain_NN is_VBZ ATCC_NP 14467T_NP ._SENT (_( iii_NP )_) M._NP fortuitum_NP third_JJ biovariant_NN complex_NN ._SENT |_SYM In_IN 1966_CD Bonicke_NP divided_VBN isolates_NNS of_IN the_DT M._NP fortuitum_NN group_NN into_IN three_CD subgroups_NNS on_IN the_DT basis_NN of_IN differences_NNS in_IN acid_JJ production_NN from_IN carbohydrates_NNS and_CC designated_VBN them_PP biotypes_NNS A_NP ,_, B_NP ,_, and_CC C_NP ._SENT Biotype_NN A_NP had_VBD no_DT unique_JJ carbohydrates_NNS ,_, biotype_NN B_NN was_VBD mannitol_NN positive_JJ ,_, while_IN biotype_NN C_NP was_VBD mannitol_NN and_CC inositol_NN positive_NN ._SENT Subsequently_RB ,_, Pattyn_NP et_FW al._FW renamed_VBD these_DT three_CD Bonicke_NP biotypes_NNS M._NP fortuitum_NN biovariant_NN fortuitum_NN ,_, M._NP fortuitum_NN biovariant_NN peregrinum_NN ,_, and_CC an_DT unnamed_JJ third_JJ biovariant_NN ._SENT In_IN 1984_CD ,_, Tsang_NP et_FW al._FW used_VBN a_DT combination_NN of_IN chemical_NN analysis_NN ,_, seroagglutination_NN ,_, and_CC enzyme-linked_JJ immunosorbent_JJ assay_NN to_TO compare_VB the_DT glycolipids_NNS of_IN the_DT RGM_NP and_CC provided_VBD evidence_NN that_IN M._NP fortuitum_NN biovar_NN peregrinum_NN was_VBD a_DT separate_JJ species_NN ._SENT M._NP fortuitum_NN biovar_NN peregrinum_NN was_VBD later_RBR confirmed_VBN as_IN an_DT independent_JJ species_NN ,_, as_IN M._NP peregrinum_NN ,_, based_VBN on_IN genomic_JJ DNA-DNA_NP relatedness_NN studies_NNS by_IN Levy-Frebault_NP et_FW al._FW and_CC Kusonoki_NP and_CC Ezaki_NP that_WDT showed_VBD <70_JJ %_NN genomic_JJ DNA-DNA_NP homology_NN of_IN M._NP peregrinum_NP (_( ATCC_NP 14467T_NP )_) to_TO other_JJ RGM_NP species_NNS ._SENT By_IN 16S_NP rDNA_NP sequencing_NP ,_, M._NP peregrinum_NP (_( ATCC_NP 14467T_NP )_) is_VBZ unique_JJ ,_, with_IN a_DT Hamming_NP distance_NN of_IN 9_CD to_TO 15_CD bp_NN from_IN other_JJ members_NNS of_IN the_DT M._NP fortuitum_NN group_NN ._SENT Wallace_NP et_FW al._FW noted_VBD two_CD subgroups_NNS within_IN M._NP peregrinum_NN ._SENT One_CD group_NN contained_VBD the_DT ATCC_NP type_NN strain_NN (_( ATCC_NP 14467T_NP )_) ,_, which_WDT was_VBD pipemidic_JJ acid_NN susceptible_JJ ;_: while_IN the_DT other_JJ ,_, represented_VBN by_IN ATCC_NP 35755_CD ,_, was_VBD pipemidic_JJ acid_JJ resistant_NN ._SENT The_DT two_CD groups_NNS have_VBP different_JJ PRA_NP patterns_NNS with_IN the_DT hsp65_JJ gene_NN ._SENT An_DT analysis_NN of_IN the_DT taxonomic_JJ status_NN of_IN this_DT second_JJ group_NN using_VBG phenotypic_JJ and_CC genetic_JJ analysis_NN is_VBZ ongoing_JJ (_( M._NP F._NP Schinsky_NP ,_, R._NP E._NP Morey_NP ,_, M._NP P._NP Douglas_NP ,_, A._NP G._NP Steigerwalt_NP ,_, R._NP W._NP Wilson_NP ,_, M._NP M._NP Floyd_NP ,_, M._NP I._NP Daneshvar_NP ,_, B._NP A._NP Brown-Elliott_NP ,_, R._NP J._NP Wallace_NP ,_, Jr._NP ,_, M._NP M._NP McNeil_NP ,_, D._NP J._NP Brenner_NP ,_, and_CC J._NP M._NP Brown_NP ,_, unpublished_JJ )_) ._SENT M._NP fortuitum_NN biovar_NN fortuitum_NN was_VBD also_RB elevated_VBN to_TO species_NN status_NN (_( M._NP fortuitum_NN )_) based_VBN on_IN DNA-DNA_NP pairing_VBG studies_NNS which_WDT showed_VBD <70_JJ %_NN homology_NN of_IN M._NP fortuitum_NP ATCC_NP 6841T_JJ to_TO other_JJ taxa_NNS (_( ,_, )_) ._SENT By_IN 16S_NP rDNA_NP sequencing_NP ,_, M._NP fortuitum_NP differs_VBZ by_IN only_RB 6_CD bp_NN from_IN the_DT unnamed_JJ third_JJ biovariant_JJ sorbitol-negative_JJ group_NN ,_, by_IN 8_CD bp_NN from_IN M._NP senegalense_NN ,_, and_CC by_IN 15_CD bp_NN from_IN M._NP peregrinum_NP (_( ATCC_NP 14467T_NP )_) ._SENT The_DT unnamed_JJ third_JJ biovariant_NN ,_, first_RB described_VBN by_IN Bonicke_NP in_IN 1966_CD ,_, was_VBD later_RBR characterized_VBN and_CC then_RB subdivided_VBN into_IN two_CD groups_NNS by_IN Wallace_NP et_FW al._FW on_IN the_DT basis_NN of_IN a_DT number_NN of_IN characteristics_NNS including_VBG sorbitol_NN utilization_NN ._SENT The_DT two_CD unnamed_JJ third_JJ biovariant_NN groups_NNS were_VBD known_VBN as_IN M._NP fortuitum_NP third_JJ biovariant_NN ,_, sorbitol_NN positive_NN ,_, and_CC M._NP fortuitum_NP third_JJ biovariant_NN ,_, sorbitol_NN negative_JJ ._SENT By_IN 16S_NP rDNA_NP sequencing_NP ,_, these_DT two_CD groups_NNS had_VBD a_DT Hamming_NP distance_NN of_IN 9_CD ,_, with_IN proposed_VBN representative_NN strains_NNS being_VBG ATCC_NP 49403_CD (_( sorbitol_NN positive_NN )_) and_CC ATCC_NP 49404_CD (_( sorbitol_NN negative_NN )_) ._SENT They_PP differed_VBD by_IN up_IN to_TO 20_CD bp_NN from_IN other_JJ M._NP fortuitum_NN group_NN members_NNS ._SENT Both_DT sorbitol-positive_JJ and_CC negative_JJ groups_NNS appeared_VBD heterogeneous_JJ ,_, especially_RB when_WRB studied_VBN for_IN beta-lactamase_NN alleles_NNS but_CC also_RB when_WRB compared_VBN by_IN PRA_NP of_IN the_DT hsp65_JJ gene_NN ._SENT (_( a_DT )_) M._NP houstonense_NP and_CC M._NP bonickeii_NP (_( proposed_VBN species_NN )_) ._SENT Investigations_NNS currently_RB under_IN way_NN may_MD better_RBR delineate_VB the_DT multiple_JJ taxa_NNS or_CC species_NNS within_IN the_DT third_JJ biovariant_NN complex_NN ._SENT Currently_RB ,_, at_IN least_JJS six_CD new_JJ species_NNS have_VBP been_VBN delineated_VBN ._SENT The_DT majority_NN of_IN the_DT sorbitol-positive_JJ group_NN have_VBP been_VBN renamed_VBN M._NP houstonense_NN ,_, while_IN the_DT majority_NN of_IN the_DT sorbitol-negative_JJ group_NN have_VBP been_VBN renamed_VBN M._NP bonickei_NP (_( Schinsky_NP et_FW al._FW ,_, Abstr_NP ._SENT 12th_JJ Int_NP ._SENT Symp_NP ._SENT Biol_NP ._SENT Actino_NP ._SENT )_) ._SENT Additional_JJ details_NNS of_IN these_DT species_NNS await_VBP publication_NN of_IN the_DT entire_JJ study_NN ._SENT (_( b_LS )_) M._NP septicum.M_NN ._SENT septicum_NN is_VBZ one_CD of_IN the_DT new_JJ species_NN within_IN the_DT third_JJ biovariant_NN complex_NN ._SENT The_DT type_NN strain_NN (_( ATCC_NP 700731T_NP )_) was_VBD the_DT causative_JJ agent_NN of_IN central-_NN line_NN sepsis_NN in_IN a_DT child_NN with_IN metastatic_JJ hepatoblastoma_NN ._SENT By_IN HPLC_NP analysis_NN of_IN mycolic_JJ acids_NNS ,_, the_DT isolate_NN was_VBD distinctive_JJ but_CC closely_RB related_VBN to_TO other_JJ members_NNS of_IN the_DT M._NP fortuitum_NN group_NN ,_, including_VBG M._NP senegalense_NN ._SENT Standard_JJ biochemical_JJ testing_NN showed_VBD the_DT isolate_NN to_TO be_VB similar_JJ to_TO members_NNS of_IN the_DT unnamed_JJ third_JJ biovariant_JJ complex_JJ sorbitol-negative_JJ group_NN (_( i.e._FW ,_, mannitol_NN positive_NN ,_, inositol_NN positive_NN ,_, sorbitol_NN negative_JJ )_) ._SENT Although_IN initial_JJ testing_NN showed_VBD the_DT isolate_NN to_TO be_VB arylsulfatase_NN negative_JJ ,_, it_PP has_VBZ been_VBN found_VBN to_TO be_VB positive_JJ in_IN other_JJ laboratories_NNS (_( K._NP Jost_NP ,_, unpublished_JJ data_NNS )_) ._SENT Analysis_NN of_IN the_DT 16S_JJ rDNA_NN showed_VBD a_DT sequence_NN related_VBN to_TO but_CC not_RB identical_JJ to_TO M._NP fortuitum_NP ,_, M._NP peregrinum_NN ,_, and_CC M._NP senegalense_NP (_( Schinsky_NP et_FW al._FW ,_, Abstr_NP ._SENT 12th_JJ Int_NP ._SENT Symp_NP ._SENT Biol_NP ._SENT Actino_NP ._SENT )_) ._SENT (_( c_LS )_) M._NP mageritense.The_NNS first_JJ five_CD reported_VBD organisms_NNS in_IN the_DT new_JJ species_NN M._NP mageritense_NN were_VBD isolated_VBN from_IN human_JJ sputa_NNS in_IN two_CD hospitals_NNS in_IN Spain_NP but_CC were_VBD not_RB considered_VBN clinically_RB significant_JJ ._SENT Recently_RB ,_, six_CD clinical_JJ isolates_NNS of_IN this_DT species_NNS were_VBD recovered_VBN in_IN the_DT United_NP States_NPS ,_, four_CD of_IN which_WDT were_VBD associated_VBN with_IN clinical_JJ disease_NN ._SENT Phenotypically_RB ,_, by_IN antibiotic_JJ susceptibility_NN patterns_NNS and_CC biochemical_JJ tests_NNS ,_, isolates_NNS of_IN M._NP mageritense_NN resemble_VBP sorbitol-positive_JJ members_NNS of_IN the_DT M._NP fortuitum_NN third_JJ biovariant_NN complex_NN (_( positive_JJ for_IN mannitol_NN ,_, inositol_NN ,_, and_CC sorbitol_NN )_) ._SENT By_IN sequencing_VBG of_IN its_PP$ 16S_JJ rDNA_NN ,_, however_RB ,_, genetically_RB ,_, M._NP mageritense_NN is_VBZ more_RBR closely_RB aligned_VBN with_IN members_NNS of_IN the_DT M._NP smegmatis_NN group_NN ._SENT M._NP mageritense_NN differs_VBZ by_IN only_RB 9_CD bp_NN from_IN the_DT type_NN strain_NN of_IN M._NP wolinskyi_NP (_( ATCC_NP 700010T_NP )_) ,_, by_IN 16_CD bp_NN from_IN the_DT type_NN strain_NN of_IN M._NP goodii_NP (_( ATCC_NP 700504T_NP )_) ,_, and_CC by_IN 18_CD bp_NN from_IN the_DT type_NN strain_NN of_IN M._NP smegmatis_NP sensu_NP stricto_NP (_( ATCC_NP 19420T_NP )_) ._SENT It_PP generally_RB differs_VBZ by_IN 23_CD to_TO 28_CD bp_NN from_IN members_NNS of_IN the_DT M._NP fortuitum_NN group_NN ._SENT Future_JJ phenotypic_JJ and_CC molecular_JJ studies_NNS of_IN M._NP mageritense_NN that_WDT include_VBP larger_JJR numbers_NNS of_IN isolates_NNS may_MD provide_VB a_DT more_RBR complete_JJ and_CC accurate_JJ taxonomic_JJ placement_NN of_IN this_DT species_NN ._SENT (_( iv_NP )_) M._NP mucogenicum_NN ._SENT |_SYM M._NP mucogenicum_NN has_VBZ been_VBN recognized_VBN as_IN a_DT species_NN since_IN 1995_CD ._SENT The_DT organism_NN was_VBD first_RB called_VBN M._NP chelonae-like_JJ organism_NN (_( MCLO_NP )_) in_IN 1982_CD ,_, when_WRB it_PP was_VBD reported_VBN as_IN the_DT etiologic_JJ agent_NN in_IN a_DT peritonitis_NN outbreak_NN involving_VBG two_CD peritoneal_JJ dialysis_NN units_NNS ._SENT It_PP was_VBD given_VBN the_DT designation_NN MCLO_NP because_IN the_DT outbreak_NN strain_NN ,_, just_RB as_IN M._NP chelonae_NNS ,_, was_VBD nitrate_NN negative_JJ and_CC growth_NN was_VBD inhibited_VBN on_IN 5_CD %_NN NaCl_NP ._SENT In_IN 1993_CD ,_, a_DT large_JJ number_NN of_IN sporadic_JJ clinical_JJ isolates_NNS were_VBD evaluated_VBN by_IN Wallace_NP and_CC colleagues_NNS (_( 200_CD )_) by_IN using_VBG biochemical_JJ reactions_NNS ,_, HPLC_NP of_IN mycolic_JJ esters_NNS ,_, and_CC antibiotic_JJ susceptibility_NN patterns_NNS ._SENT Subsequently_RB ,_, in_IN 1995_CD ,_, Springer_NP et_FW al._FW proposed_VBN the_DT name_NN M._NP mucogenicum_NN for_IN this_DT organism_NN group_NN ,_, reflecting_VBG the_DT highly_RB mucoid_JJ character_NN of_IN the_DT isolates_NNS ._SENT This_DT species_NN has_VBZ always_RB been_VBN grouped_VBN with_IN the_DT M._NP chelonae-abscessus_NN group_NN ,_, but_CC is_VBZ unlike_IN that_DT group_NN in_IN that_IN approximately_RB 50_CD %_NN of_IN isolates_NNS are_VBP nitrate_NN positive_JJ ,_, have_VBP a_DT weak_JJ but_CC positive_JJ iron_NN uptake_NN ,_, and_CC are_VBP much_RB more_RBR susceptible_JJ to_TO antibiotics_NNS including_VBG the_DT fluoroquinolones_NNS ,_, amoxicillin-clavulanic_JJ acid_NN ,_, polymyxin_NN B_NN ,_, and_CC cephalothin_NN ._SENT In_IN addition_NN ,_, by_IN 16S_NP rDNA_NP sequencing_NP M._NP mucogenicum_NN is_VBZ more_RBR closely_RB related_VBN to_TO the_DT M._NP fortuitum_NN group_NN than_IN to_TO the_DT M._NP chelonae-abscessus_NN group_NN ._SENT The_DT type_NN strain_NN (_( ATCC_NP 49650T_NP )_) of_IN M._NP mucogenicum_NN differs_VBZ by_IN 11_CD to_TO 18_CD bp_NN from_IN members_NNS of_IN the_DT M._NP fortuitum_NN group_NN but_CC differs_VBZ by_IN 35_CD bp_NN from_IN M._NP abscessus_NN and_CC by_IN 38_CD bp_NN from_IN M._NP chelonae_NNS ._SENT Hence_RB ,_, we_PP propose_VBP to_TO add_VB this_DT species_NN to_TO other_JJ members_NNS within_IN the_DT M._NP fortuitum_NN group_NN ._SENT (_( v_NN )_) M._NP senegalense_NN ._SENT |_SYM M._NP senegalense_NN was_VBD originally_RB described_VBN by_IN Chamoiseau_NP in_IN 1973_CD as_IN a_DT subspecies_NN of_IN M._NP farcinogenes_NNS ._SENT Later_RBR ,_, however_RB ,_, it_PP was_VBD recognized_VBN as_IN a_DT different_JJ species_NNS closely_RB related_VBN to_TO M._NP fortuitum_NN ._SENT Like_IN M._NP peregrinum_NP ,_, M._NP senegalense_NN is_VBZ positive_JJ only_RB on_IN mannitol_NN ,_, when_WRB tested_VBN on_IN common_JJ sugars_NNS ,_, but_CC has_VBZ a_DT unique_JJ PRA_NP pattern_NN with_IN the_DT hsp65_JJ Telenti_NP fragment_NN ._SENT Its_PP$ 16S_JJ rDNA_NN sequence_NN differs_VBZ by_IN 4_CD bp_NN from_IN the_DT unnamed_JJ M._NP fortuitum_NN third_JJ biovariant_NN complex_NN (_( sorbitol-positive_JJ )_) strain_NN ATCC_NP 49403_CD ;_: by_IN 5_CD bp_NN from_IN the_DT unnamed_JJ third_JJ biovariant_NN complex_NN (_( sorbitol-negative_JJ )_) strain_NN ATCC_NP 49404_CD ;_: and_CC by_IN only_RB 8_CD bp_NN from_IN M._NP fortuitum_NP (_( ATCC_NP 6841T_NP )_) ._SENT By_IN DNA_NP comparison_NN studies_NNS ,_, however_RB ,_, it_PP is_VBZ a_DT species_NN apart_RB from_IN these_DT other_JJ organism_NN groups_NNS ._SENT Type_NN of_IN disease_NN ._SENT |_SYM (_( i_NP )_) Community-acquired_JJ disease_NN ._SENT |_SYM The_DT M._NP fortuitum_NN group_NN accounts_NNS for_IN 60_CD %_NN of_IN cases_NNS of_IN localized_JJ cutaneous_JJ infections_NNS caused_VBN by_IN RGM_NP but_CC is_VBZ a_DT rare_JJ cause_NN of_IN chronic_JJ mycobacterial_JJ pulmonary_JJ disease_NN ._SENT Localized_JJ cutaneous_JJ disease_NN generally_RB occurs_VBZ in_IN previously_RB healthy_JJ hosts_NNS ,_, and_CC drug-induced_JJ immune_JJ suppression_NN appears_VBZ to_TO result_VB in_IN minimal_JJ increase_NN in_IN this_DT risk_NN ._SENT Wallace_NP et_FW al._FW studied_VBN 123_CD patients_NNS with_IN extrapulmonary_JJ disease_NN caused_VBN by_IN RGM_NP and_CC reported_VBD that_DT 76_CD (_( 63_CD %_NN )_) of_IN these_DT infections_NNS were_VBD due_JJ to_TO the_DT M._NP fortuitum_NN group_NN ._SENT Griffith_NP et_FW al._FW studied_VBN 154_CD patients_NNS with_IN pulmonary_JJ disease_NN due_JJ to_TO RGM_NP and_CC reported_VBD that_IN only_RB 16_CD %_NN of_IN the_DT infections_NNS encountered_VBN during_IN the_DT 15-year_JJ study_NN were_VBD due_JJ to_TO the_DT M._NP fortuitum_NN group_NN ._SENT The_DT M._NP fortuitum_NN group_NN was_VBD a_DT common_JJ lung_NN pathogen_NN (_( 50_CD %_NN of_IN cases_NNS )_) only_RB in_IN the_DT setting_NN of_IN chronic_JJ aspiration_NN secondary_JJ to_TO underlying_VBG gastroesophageal_JJ diseases_NNS such_JJ as_IN achalasia_NN ._SENT Approximately_RB 25_CD %_NN of_IN M._NP fortuitum_NN group_NN infections_NNS based_VBN on_IN one_CD study_NN have_VBP been_VBN associated_VBN with_IN a_DT variety_NN of_IN diseases_NNS other_JJ than_IN skin_NN or_CC soft_JJ tissue_NN infections_NNS including_VBG cervical_JJ lymphadenitis_NN ,_, mastoiditis_NN ,_, and_CC meningitis_NN ._SENT ._SENT Species_NNS in_IN the_DT M._NP fortuitum_NN group_NN are_VBP relatively_RB rare_JJ causes_NNS of_IN disseminated_VBN disease_NN compared_VBN to_TO other_JJ pathogenic_JJ RGM_NP species_NNS ,_, especially_RB M._NP chelonae_NP and_CC M._NP abscessus_NP ._SENT (_( ii_NP )_) Health_NP care-associated_JJ disease_NN ._SENT |_SYM The_DT M._NP fortuitum_NN group_NN is_VBZ responsible_JJ for_IN the_DT majority_NN (_( 60_CD to_TO 80_CD %_NN )_) of_IN cases_NNS of_IN postsurgical_JJ wound_NN infections_NNS and_CC catheter_NN infections_NNS caused_VBN by_IN the_DT RGM_NP ._SENT Most_JJS of_IN the_DT responsible_JJ organisms_NNS are_VBP M._NP fortuitum_NN and_CC are_VBP detailed_VBN below_IN in_IN the_DT specific_JJ section_NN on_IN M._NP fortuitum_NN ._SENT Geography_NN ._SENT |_SYM Cutaneous_JJ disease_NN caused_VBN by_IN the_DT M._NP fortuitum_NN group_NN ,_, although_IN reported_VBN from_IN all_DT over_IN the_DT United_NP States_NPS and_CC worldwide_RB ,_, has_VBZ been_VBN recognized_VBN most_RBS commonly_RB in_IN the_DT southeastern_JJ United_NP States_NPS ._SENT A_DT report_NN in_IN 1989_CD indicated_VBD that_IN about_RB 80_CD %_NN of_IN wound_NN isolates_NNS related_VBN to_TO cardiac_JJ surgery_NN were_VBD from_IN seven_CD southern_JJ coastal_JJ states_NNS :_: Texas_NP ,_, Louisiana_NP ,_, Georgia_NP ,_, Maryland_NP ,_, Alabama_NP ,_, Florida_NP ,_, and_CC South_NP Carolina_NP ._SENT A_DT second_JJ report_NN published_VBN in_IN the_DT same_JJ year_NN found_VBD that_IN 92_CD %_NN of_IN 37_CD identified_VBN cases_NNS of_IN surgical_JJ wound_NN infections_NNS following_VBG augmentation_NN mammaplasty_NN were_VBD in_IN patients_NNS from_IN southern_JJ coastal_JJ states_NNS ,_, with_IN the_DT majority_NN being_VBG from_IN Texas_NP ,_, Florida_NP ,_, and_CC North_NP Carolina_NP ._SENT Approximately_RB 80_CD %_NN of_IN isolates_NNS in_IN both_DT studies_NNS combined_VBN belonged_VBD to_TO the_DT M._NP fortuitum_NN group_NN ._SENT Individual_JJ taxa_NNS ._SENT |_SYM (_( i_NP )_) M._NP fortuitum_NN ._SENT |_SYM (_( a_DT )_) Community-acquired_JJ disease_NN ._SENT In_IN essentially_RB all_DT series_NN of_IN community-acquired_NN or_CC health_NN care-associated_JJ disease_NN attributed_VBD to_TO the_DT M._NP fortuitum_NN group_NN ,_, most_JJS or_CC all_DT of_IN the_DT cases_NNS are_VBP due_JJ to_TO M._NP fortuitum_NN ._SENT In_IN a_DT study_NN of_IN 154_CD patients_NNS with_IN RGM_NP pulmonary_JJ disease_NN ,_, Griffith_NP et_FW al._FW reported_VBD 13_CD %_NN of_IN infections_NNS were_VBD due_JJ to_TO M._NP fortuitum_NN and_CC only_RB 3_CD %_NN were_VBD due_JJ to_TO other_JJ members_NNS of_IN the_DT M._NP fortuitum_NN group_NN ._SENT In_IN a_DT series_NN of_IN cases_NNS of_IN extrapulmonary_JJ disease_NN cased_VBN by_IN the_DT M._NP fortuitum_NN group_NN ,_, Wallace_NP et_FW al._FW reported_VBD that_IN almost_RB 80_CD %_NN of_IN the_DT infections_NNS were_VBD due_JJ to_TO M._NP fortuitum_NN ._SENT Disseminated_VBN infections_NNS with_IN M._NP fortuitum_NN are_VBP rare_JJ ._SENT The_DT first_JJ case_NN report_NN appeared_VBD in_IN 1990_CD ,_, when_WRB Sack_NP described_VBD a_DT patient_NN with_IN a_DT history_NN of_IN intravenous_JJ IV_NP drug_NN abuse_NN and_CC AIDS_NP ,_, who_WP had_VBD cutaneous_JJ lesions_NNS from_IN which_WDT M._NP fortuitum_NN was_VBD isolated_VBN ._SENT Cultures_NNS of_IN specimens_NNS from_IN lymph_NN nodes_NNS ,_, urine_NN ,_, pleural_JJ effusions_NNS ,_, and_CC feces_NN all_RB yielded_VBD M._NP fortuitum_NP ._SENT (_( b_LS )_) Health_NP care-associated_JJ disease_NN ._SENT M._NP fortuitum_NP has_VBZ been_VBN implicated_VBN in_IN numerous_JJ outbreaks_NNS of_IN hospital_NN or_CC health_NN care-associated_JJ infections_NNS ._SENT These_DT include_VBP sternal_JJ wound_NN infections_NNS ;_: postinjection_NN abscesses_NNS related_VBN to_TO electromyography_NN needles_NNS ;_: and_CC a_DT respiratory_JJ disease_NN outbreak_NN in_IN Washington_NP ,_, D.C._NP ._SENT M._NP fortuitum_NP has_VBZ also_RB been_VBN recovered_VBN from_IN sporadic_JJ cases_NNS of_IN surgical_JJ wound_NN infections_NNS and_CC catheter-related_JJ infections_NNS and_CC is_VBZ the_DT most_RBS common_JJ RGM_NP species_NNS in_IN women_NNS with_IN surgical_JJ wound_NN infections_NNS following_VBG augmentation_NN mammaplasty_NN ._SENT Details_NNS of_IN some_DT of_IN the_DT outbreaks_NNS are_VBP listed_VBN below_RB ._SENT Cardiac_JJ disease_NN outbreaks_NNS ._SENT Isolates_NNS of_IN M._NP fortuitum_NN have_VBP been_VBN found_VBN in_IN sternal_JJ wound_NN infections_NNS in_IN Hong_NP Kong_NP ,_, Colorado_NP ,_, Nebraska_NP ,_, and_CC Texas_NP ._SENT Interestingly_RB ,_, three_CD of_IN the_DT four_CD involved_JJ multiple_JJ RGM_NP species_NNS or_CC multiple_JJ strains_NNS of_IN the_DT same_JJ species_NN ._SENT The_DT first_JJ outbreak_NN occurred_VBD in_IN 1976_CD in_IN a_DT hospital_NN in_IN Colorado_NP ._SENT Of_IN nine_CD patients_NNS who_WP underwent_VBD cardiovascular_JJ surgery_NN within_IN a_DT 2-week_JJ period_NN ,_, four_CD became_VBD infected_VBN with_IN a_DT single_JJ genetic_JJ strain_NN of_IN M._NP fortuitum_NN ._SENT Despite_IN intense_JJ infection_NN control_NN efforts_NNS to_TO recover_VB the_DT organism_NN from_IN environmental_JJ sources_NNS and_CC subsequent_JJ molecular_JJ analysis_NN of_IN the_DT isolates_NNS recovered_VBD ,_, no_DT environmental_JJ source_NN was_VBD identified_VBN ._SENT In_IN 1981_CD ,_, Preheim_NP and_CC colleagues_NNS (_( L._NP C._NP Preheim_NP ,_, M._NP J._NP Bittner_NP ,_, D._NP K._NP Giger_NP ,_, and_CC W._NP E._NP Sanders_NP Jr._NP ,_, Program_NP Abstr_NP ._SENT 22nd_JJ Intersci_NP ._SENT Conf_NP ._SENT Antimicrob_NN ._SENT Agents_NPS Chemother_NP ._SENT ,_, abstr_NN ._SENT 564_CD ,_, 1982_CD )_) reported_VBD an_DT outbreak_NN in_IN a_DT Nebraska_NP hospital_NN that_WDT involved_VBD five_CD patients_NNS who_WP developed_VBD sternotomy_NN infections_NNS following_VBG coronary_JJ bypass_NN surgery_NN ._SENT All_DT had_VBD multiple_JJ debridements_NNS ._SENT One_CD patient_NN died_VBN (_( Preheim_NP et_FW al._FW ,_, 22nd_JJ ICAAC_NN )_) ._SENT Later_RBR analysis_NN by_IN plasmid_NN profiles_NNS ,_, multilocus_NN enzyme_NN electrophoresis_NN (_( MEE_NP )_) ,_, and_CC pulsed-field_JJ gel_NN electrophoresis_NN showed_VBD the_DT presence_NN of_IN two_CD strains_NNS of_IN M._NP fortuitum_NN ._SENT Another_DT outbreak_NN in_IN 1981_CD involving_VBG M._NP abscessus_NP and_CC M._NP fortuitum_NN ,_, was_VBD reported_VBN in_IN a_DT hospital_NN in_IN Corpus_NP Christi_NP ,_, Tex._NP ._SENT Of_IN 51_CD patients_NNS undergoing_VBG surgery_NN over_IN a_DT 6-month_JJ period_NN ,_, 6_CD (_( 11.3_CD %_NN )_) developed_VBN infections_NNS with_IN one_CD of_IN these_DT RGM_NP ._SENT One_CD patient_NN with_IN sternal_JJ wound_NN infection_NN due_JJ to_TO M._NP fortuitum_NN died_VBD as_IN a_DT result_NN of_IN complications_NNS from_IN sternectomy_NN and_CC antimicrobial_JJ therapy_NN ._SENT A_DT subsequent_JJ study_NN was_VBD performed_VBN in_IN which_WDT culture_NN media_NNS were_VBD inoculated_VBN with_IN samples_NNS taken_VBN from_IN environmental_JJ sites_NNS including_VBG the_DT municipal_JJ water_NN system_NN ,_, water_NN from_IN the_DT cold_JJ water_NN tap_NN in_IN the_DT operating_VBG room_NN ,_, ice_NN machines_NNS ,_, swabs_NNS of_IN lamps_NNS ,_, oxygen_NN tanks_NNS ,_, suction_NN apparatus_NN ,_, and_CC commercial_JJ bone_NN wax_NN ._SENT Multiple_JJ sites_NNS were_VBD culture_NN positive_JJ for_IN M._NP fortuitum_NN strains_NNS which_WDT ,_, by_IN MEE_NP and_CC subsequent_JJ pulsed-field_JJ gel_NN electrophoresis_NN ,_, were_VBD identical_JJ to_TO the_DT disease_NN strains_NNS ._SENT This_DT is_VBZ the_DT first_JJ and_CC only_JJ cardiac_JJ surgery_NN outbreak_NN in_IN which_WDT the_DT piped-water_NN system_NN has_VBZ been_VBN implicated_VBN as_IN the_DT source_NN of_IN the_DT pathogenic_JJ RGM_NP ._SENT In_IN this_DT case_NN ,_, the_DT cardioplegia_NN solution_NN was_VBD cooled_VBN in_IN ice_NN made_VBN from_IN tap_NN water_NN contaminated_VBN with_IN the_DT outbreak_NN strains_NNS ._SENT The_DT fourth_JJ and_CC latest_JJS outbreak_NN of_IN M._NP fortuitum_NN infection_NN following_VBG cardiac_JJ surgery_NN came_VBD from_IN Hong_NP Kong_NP ._SENT Both_DT M._NP fortuitum_NP and_CC M._NP peregrinum_NN were_VBD implicated_VBN ._SENT The_DT outbreak_NN spanned_VBD the_DT years_NNS 1987_CD to_TO 1989_CD ,_, and_CC 7_CD (_( 33_CD %_NN )_) of_IN 21_CD wound_NN infections_NNS were_VBD due_JJ to_TO M._NP fortuitum_NN ._SENT (_( Details_NNS of_IN the_DT M._NP peregrinum_NN strains_NNS are_VBP presented_VBN in_IN the_DT M._NP peregrinum_NN section_NN ,_, below_RB ._SENT )_) Subsequent_JJ ribotyping_NN and_CC susceptibility_NN testing_NN suggested_VBD that_IN multiple_JJ strains_NNS were_VBD involved_VBN ._SENT No_DT source_NN for_IN the_DT prolonged_JJ Hong_NP Kong_NP outbreak_NN was_VBD identified_VBN ._SENT Postinjection_NN abscess_NN disease_NN ._SENT Most_JJS outbreaks_NNS of_IN postinjection_NN abscesses_NNS caused_VBN by_IN RGM_NP have_VBP involved_VBN M._NP abscessus_NN ._SENT However_RB ,_, Nolan_NP et_FW al._FW reported_VBD an_DT outbreak_NN of_IN M._NP fortuitum_NN in_IN five_CD (_( 83_CD %_NN )_) of_IN six_CD patients_NNS undergoing_VBG electromyography_NN at_IN a_DT facility_NN in_IN Washington_NP state_NN ._SENT The_DT outbreak_NN was_VBD traced_VBN to_TO a_DT break_NN in_IN a_DT manual_JJ procedure_NN used_VBN for_IN sterilizing_VBG the_DT reusable_JJ needle_NN electrodes_NNS ._SENT When_WRB subsequent_JJ sterilizations_NNS were_VBD performed_VBN using_VBG an_DT autoclave_NN ,_, no_DT further_JJR cases_NNS were_VBD reported_VBN ._SENT Plastic_JJ surgery-related_JJ disease_NN ._SENT No_DT large_JJ outbreaks_NNS of_IN wound_NN infection_NN following_VBG plastic_JJ surgery_NN due_JJ to_TO M._NP fortuitum_NN have_VBP been_VBN reported_VBN ,_, but_CC sporadic_JJ wound_NN infections_NNS following_VBG plastic_JJ surgery_NN have_VBP been_VBN well_RB documented_VBN ._SENT Many_JJ of_IN these_DT infections_NNS ,_, involving_VBG M._NP fortuitum_NN ,_, occurred_VBN after_IN augmentation_NN mammaplasty_NN ._SENT A_DT study_NN by_IN Wallace_NP et_FW al._FW identified_VBN 37_CD cases_NNS of_IN surgical_JJ wound_NN infection_NN with_IN RGM_NP following_VBG augmentation_NN mammaplasty_NN ._SENT Of_IN these_DT isolates_NNS ,_, 26_CD (_( 70_CD %_NN )_) were_VBD identified_VBN as_IN M._NP fortuitum_NN ._SENT Several_JJ surgeons_NNS had_VBD more_JJR than_IN one_CD case_NN ,_, suggesting_VBG that_IN local_JJ environmental_JJ factors_NNS were_VBD important_JJ to_TO disease_NN development_NN ._SENT Six_CD cases_NNS of_IN M._NP fortuitum_NN disease_NN associated_VBN with_IN spontaneous_JJ breast_NN abscesses_NNS with_IN no_DT history_NN of_IN surgery_NN or_CC trauma_NN were_VBD also_RB reported_VBN ._SENT Pseudo-outbreaks_NNS ._SENT One_CD pseudo-outbreak_NN involving_VBG M._NP fortuitum_NN occurred_VBD in_IN 1987_CD in_IN Houston_NP ,_, Tex._NP ,_, and_CC involved_JJ ice_NN contaminated_VBN with_IN M._NP fortuitum_NN ._SENT Although_IN M._NP fortuitum_NN was_VBD recovered_VBN from_IN specimens_NNS from_IN four_CD patients_NNS who_WP underwent_VBD bone_NN marrow_NN aspiration_NN ,_, none_NN of_IN the_DT patients_NNS had_VBD evidence_NN of_IN disease_NN due_JJ to_TO M._NP fortuitum_NN ._SENT It_PP was_VBD later_RBR noted_VBN that_IN each_DT of_IN the_DT patients_NNS whose_WP$ aspirates_NNS yielded_VBD M._NP fortuitum_NN on_IN culture_NN also_RB had_VBD viral_JJ cultures_NNS performed_VBN ,_, and_CC this_DT required_VBD that_IN the_DT syringe_NN containing_VBG the_DT aspirate_NN be_VB plunged_VBN into_IN ice_NN for_IN transport_NN ._SENT Samples_NNS taken_VBN from_IN the_DT ice_NN machine_NN located_VBN on_IN the_DT same_JJ floor_NN as_IN the_DT patients_NNS with_IN positive_JJ aspirate_JJ samples_NNS were_VBD also_RB positive_JJ for_IN M._NP fortuitum_NN ._SENT Samples_NNS from_IN ice_NN machines_NNS on_IN other_JJ floors_NNS did_VBD not_RB grow_VB M._NP fortuitum_NN ._SENT No_DT molecular_NN typing_VBG was_VBD performed_VBN ._SENT (_( ii_NP )_) Unnamed_JJ third_JJ biovariant_JJ complex_NN including_VBG M._NP septicum_NN ,_, M._NP mageritense_NP ,_, M._NP houstonense_NP (_( proposed_VBN )_) ,_, and_CC M._NP bonickei_NP (_( proposed_VBN )_) ._SENT |_SYM Pattyn_NP et_FW al._FW published_VBN one_CD of_IN the_DT earliest_JJS studies_NNS of_IN the_DT unnamed_JJ third_JJ biovariant_NN complex_NN approximately_RB 30_CD years_NNS ago_RB ._SENT The_DT authors_NNS commented_VBD that_IN most_JJS of_IN the_DT isolates_NNS they_PP studied_VBD were_VBD environmental_JJ strains_NNS and_CC none_NN had_VBD a_DT definite_JJ disease_NN association_NN ._SENT (_( a_DT )_) Community-acquired_JJ disease_NN ._SENT In_IN 1991_CD ,_, Wallace_NP et_FW al._FW ,_, characterized_VBD 85_CD clinical_JJ isolates_NNS of_IN unnamed_JJ M._NP fortuitum_NN third_JJ biovariant_NN complex_NN ,_, all_DT of_IN which_WDT were_VBD disease_NN associated_VBN ._SENT These_DT represented_VBD 16_CD %_NN of_IN 410_CD isolates_NNS of_IN the_DT M._NP fortuitum_NN group_NN submitted_VBN to_TO a_DT Texas_NP laboratory_NN and_CC 22_CD %_NN of_IN 45_CD isolates_NNS submitted_VBN to_TO the_DT Queensland_NP ,_, Australia_NP ,_, state_NN laboratory_NN ._SENT Over_IN 75_CD %_NN of_IN the_DT infections_NNS involved_VBD skin_NN ,_, soft_JJ tissue_NN ,_, or_CC bone_NN ._SENT Clinical_JJ histories_NNS were_VBD available_JJ for_IN 52_CD patients_NNS with_IN skin_NN and_CC soft_JJ tissue_NN infections_NNS ,_, and_CC the_DT type_NN of_IN injury_NN responsible_JJ for_IN infection_NN was_VBD reported_VBN for_IN 42_CD patients_NNS ._SENT Of_IN these_DT 42_CD patients_NNS ,_, 29_CD %_NN had_VBD osteomyelitis_NN confirmed_VBN by_IN bone_NN biopsy_NN ._SENT Most_JJS infections_NNS occurred_VBD following_VBG puncture_NN wounds_NNS or_CC compound_JJ (_( open_JJ )_) fractures_NNS ._SENT Only_RB two_CD patients_NNS (_( children_NNS )_) had_VBD no_DT history_NN of_IN trauma_NN leading_VBG to_TO their_PP$ infection_NN ._SENT Metal_NN puncture_NN wounds_NNS (_( 48_CD %_NN )_) or_CC motor_NN vehicle_NN accidents_NNS (_( 26_CD %_NN )_) were_VBD the_DT most_RBS common_JJ histories_NNS given_VBN ,_, and_CC approximately_RB 40_CD %_NN of_IN the_DT injuries_NNS involved_VBD the_DT foot_NN or_CC leg_NN ._SENT Stepping_VBG on_IN a_DT nail_NN was_VBD the_DT classic_JJ scenario_NN ._SENT No_DT cases_NNS of_IN disseminated_VBN disease_NN were_VBD observed_VBN in_IN this_DT study_NN ,_, and_CC ,_, to_TO date_NN ,_, none_NN have_VBP been_VBN reported_VBN by_IN other_JJ authors_NNS ._SENT This_DT study_NN also_RB identified_VBD 26_CD isolates_NNS of_IN the_DT third_JJ biovariant_JJ complex_NN from_IN pulmonary_JJ sources_NNS ._SENT Clinical_JJ significance_NN was_VBD not_RB determined_VBN ,_, but_CC almost_RB certainly_RB some_DT of_IN these_DT were_VBD disease_NN producing_NN ._SENT None_NN of_IN these_DT isolates_NNS were_VBD studied_VBN by_IN molecular_JJ methods_NNS that_WDT would_MD identify_VB them_PP as_IN one_CD of_IN the_DT recently_RB described_VBN species_NNS within_IN the_DT complex_NN (_( i.e._FW ,_, M._NP houstonense_NP [_SYM proposed_VBN ]_SYM ,_, M._NP bonickei_NP [_SYM proposed_VBN ]_SYM ,_, M._NP septicum_NN ,_, or_CC M._NP mageritense_NP )_) (_( 190_CD ;_: Schinsky_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT (_( b_LS )_) Health_NP care-associated_JJ disease_NN ._SENT A_DT small_JJ number_NN of_IN cases_NNS have_VBP been_VBN reported_VBN in_IN association_NN with_IN hospital-acquired_JJ disease_NN in_IN other_JJ studies_NNS ,_, including_VBG wound_NN infections_NNS following_VBG cardiac_JJ surgery_NN and_CC augmentation_NN mammaplasty_NN ._SENT (_( c_LS )_) Geography_NP ._SENT The_DT original_JJ description_NN by_IN Pattyn_NP et_FW al._FW of_IN this_DT group_NN was_VBD based_VBN on_IN isolates_NNS from_IN Europe_NP and_CC Africa_NP ._SENT Later_RBR in_IN 1983_CD ,_, Levy-Frebault_NP et_FW al._FW characterized_VBD 23_CD additional_JJ isolates_NNS of_IN M._NP fortuitum_NN from_IN France_NP and_CC found_VBD 6_CD environmental_JJ isolates_NNS that_WDT were_VBD identified_VBN subsequently_RB as_IN M._NP fortuitum_NP unnamed_JJ third_JJ biovariant_NN complex_NN ._SENT A_DT later_JJR study_NN by_IN Wallace_NP et_FW al._FW included_VBD 10_CD isolates_NNS from_IN Australia_NP ._SENT The_DT remaining_VBG 70_CD isolates_NNS were_VBD from_IN the_DT United_NP States_NPS ,_, of_IN which_WDT approximately_RB 70_CD %_NN were_VBD from_IN Texas_NP ,_, 6_CD %_NN were_VBD from_IN Florida_NP ,_, and_CC 5_CD %_NN were_VBD from_IN Alabama_NP and_CC Georgia_NP ._SENT Four_CD percent_NN or_CC less_JJR of_IN the_DT third_JJ biovariant_NN isolates_NNS identified_VBN in_IN this_DT study_NN were_VBD from_IN other_JJ states_NNS including_VBG Tennessee_NP ,_, Louisiana_NP ,_, New_NP Hampshire_NP ,_, South_NP Carolina_NP ,_, Arkansas_NP ,_, and_CC Connecticut_NP (_( our_PP$ unpublished_JJ data_NNS )_) ._SENT (_( iii_NP )_) M._NP peregrinum_NN ._SENT |_SYM Currently_RB ,_, there_EX is_VBZ no_DT published_JJ series_NN or_CC review_VB evaluating_VBG the_DT clinical_JJ significance_NN of_IN M._NP peregrinum_NN ._SENT No_DT case_NN of_IN disseminated_VBN infection_NN due_JJ to_TO M._NP peregrinum_NN has_VBZ been_VBN reported_VBN ._SENT However_RB ,_, a_DT small_JJ number_NN of_IN cases_NNS of_IN sporadic_JJ infections_NNS have_VBP been_VBN reported_VBN and_CC have_VBP been_VBN associated_VBN with_IN diseases_NNS similar_JJ to_TO other_JJ members_NNS of_IN the_DT M._NP fortuitum_NN group_NN ._SENT These_DT include_VBP chronic_JJ lung_NN disease_NN ,_, sternal_JJ wound_NN infections_NNS ,_, and_CC cutaneous_JJ disease_NN ._SENT In_IN general_JJ ,_, they_PP represent_VBP only_RB 1_CD to_TO 2_CD %_NN of_IN sporadic_JJ community-acquired_NN or_CC health_NN care-associated_JJ infections_NNS due_JJ to_TO RGM_NP ._SENT M._NP peregrinum_NP has_VBZ been_VBN reported_VBN as_IN a_DT cause_NN of_IN a_DT pseudo-outbreak_NN of_IN respiratory_JJ disease_NN due_JJ to_TO a_DT contaminated_JJ ice_NN machine_NN and_CC as_IN the_DT etiologic_JJ agent_NN of_IN 67_CD %_NN of_IN cases_NNS in_IN an_DT outbreak_NN of_IN sternal_JJ wound_NN infections_NNS from_IN Hong_NP Kong_NP that_WDT occurred_VBD from_IN 1987_CD to_TO 1989_CD ._SENT (_( iv_NP )_) M._NP mucogenicum_NN ._SENT |_SYM M._NP mucogenicum_NN ,_, formerly_RB MCLO_NP ,_, was_VBD originally_RB discovered_VBN in_IN two_CD outbreaks_NNS of_IN peritonitis_NN in_IN 1976_CD and_CC 1978_CD ,_, in_IN 5_CD (_( 18_CD %_NN )_) of_IN 22_CD and_CC 5_CD (_( 63_CD %_NN )_) of_IN 8_CD patients_NNS ,_, respectively_RB ,_, undergoing_VBG intermittent_JJ chronic_JJ peritoneal_JJ dialysis_NN ._SENT Infections_NNS were_VBD traced_VBN to_TO the_DT use_NN of_IN contaminated_JJ automated_JJ chronic_JJ peritoneal_JJ dialysis_NN machines_NNS in_IN two_CD dialysis_NN centers_NNS ._SENT Seven_CD sporadic_JJ cases_NNS of_IN peritonitis_NN due_JJ to_TO M._NP mucogenicum_NN from_IN the_DT same_JJ two_CD centers_NNS were_VBD also_RB diagnosed_VBN ._SENT The_DT investigators_NNS '_POS findings_NNS suggested_VBD that_IN ineffective_JJ disinfection_NN of_IN the_DT equipment_NN followed_VBN by_IN colonization_NN of_IN the_DT machines_NNS by_IN this_DT newly_RB described_VBN species_NNS was_VBD responsible_JJ for_IN the_DT outbreaks_NNS ._SENT Three_CD studies_NNS showed_VBD that_IN M._NP mucogenicum_NN ,_, like_IN other_JJ pathogenic_JJ species_NNS of_IN RGM_NP ,_, is_VBZ relatively_RB resistant_JJ to_TO formaldehyde_NN and_CC glutaraldehyde_NN disinfectants_NNS ,_, which_WDT are_VBP typically_RB used_VBN to_TO disinfect_VB dialysis_NN equipment_NN ._SENT In_IN 1985_CD ,_, Bolan_NP et_FW al._FW described_VBD a_DT mycobacterial_JJ disease_NN outbreak_NN in_IN a_DT hemodialysis_NN center_NN in_IN Louisiana_NP ._SENT Of_IN 26_CD identified_VBN isolates_NNS ,_, 25_CD were_VBD M._NP abscessus_NN and_CC 1_CD was_VBD M._NP mucogenicum_NN ._SENT The_DT single_JJ factor_NN common_JJ to_TO all_DT patients_NNS was_VBD their_PP$ exposure_NN to_TO hemodialyzers_NNS (_( artificial_JJ kidneys_NNS )_) that_WDT had_VBD been_VBN ineffectively_RB treated_VBN with_IN concentrations_NNS of_IN disinfectant_NN (_( formaldehyde_NN )_) that_WDT were_VBD below_IN effective_JJ levels_NNS for_IN these_DT RGM_NP species_NN ._SENT Although_IN M._NP mucogenicum_NN is_VBZ often_RB recovered_VBN as_IN a_DT laboratory_NN contaminant_NN ,_, these_DT three_CD outbreaks_NNS alert_VB us_PP to_TO the_DT potential_JJ significance_NN of_IN this_DT waterborne_JJ organism_NN ._SENT In_IN 1993_CD ,_, Wallace_NP et_FW al._FW evaluated_VBN 87_CD sporadic_JJ isolates_NNS of_IN M._NP mucogenicum_NN ._SENT Of_IN these_DT isolates_NNS ,_, 54_CD (_( 62_CD %_NN )_) were_VBD respiratory_JJ ,_, and_CC only_RB 2_CD (_( 4_CD %_NN )_) of_IN them_PP (_( both_CC from_IN patients_NNS with_IN AIDS_NP )_) were_VBD clinically_RB significant_JJ ._SENT For_IN the_DT remaining_VBG 33_CD nonrespiratory_JJ isolates_NNS ,_, significant_JJ clinical_JJ diseases_NNS included_VBD posttraumatic_JJ wound_NN infections_NNS and_CC catheter-related_JJ sepsis_NN ._SENT Recovery_NN of_IN M._NP mucogenicum_NN from_IN skin_NN ,_, wound_VBD ,_, or_CC blood_NN cultures_NNS was_VBD most_RBS often_RB associated_VBN with_IN c_NN 